Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent (MIRAII)
A Randomized Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent (Niti-S Mira-Cover II Biliary Stent) to the Common Covered Metallic Biliary Stent.
Sponsor: Jong Taek, Lee
Terminated
Delayed subject enrollment
Other Biliary Stricture trials with similar outcome
Listed as NCT01413386, this NA trial focuses on Biliary Stricture and Malignant Neoplasms and remains terminated or withdrawn. Sponsored by Jong Taek, Lee, it has been updated 8 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Apr 2020 — Jan 2021 [monthly]
Terminated NA
Phase: PHASE3 → NA
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2020 [monthly]
Terminated PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Terminated PHASE3
Status: Unknown Status → Terminated
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status PHASE3
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Jong Taek, Lee
For direct contact, visit the study record on ClinicalTrials.gov .